IDEXX LABORATORIES INC /DE Derivative Liability, Fair Value, Gross Liability
IDEXX LABORATORIES INC /DE (IDXX) had Derivative Liability, Fair Value, Gross Liability of $117.22 million as of 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Notes › Offsetting › Derivative Liability, Subject to Master Netting Arrangement, after Offset and Deduction › Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2018-05-04
- 2018-03-31: Derivative Liability, Fair Value, Gross Liability $117.22M.
- 2017-12-31: Derivative Liability, Fair Value, Gross Liability $113.03M.
- 2017-09-30: Derivative Liability, Fair Value, Gross Liability $111.66M.
- 2017-06-30: Derivative Liability, Fair Value, Gross Liability $105.39M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2018-03-31 | $117.22M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $113.03M 10-Q · filed 2018-05-04 |
| 2017-09-30 | $111.66M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $105.39M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $96.75M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $94.75M 10-Q · filed 2017-10-31 |
| 2016-09-30 | $103.05M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $102.23M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $104.99M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $98.83M 10-Q · filed 2016-11-01 |
| 2015-09-30 | $102.08M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $101.90M 10-Q · filed 2015-07-30 |
| 2014-12-31 | $2.44M 10-Q · filed 2015-10-28 |
| 2014-09-30 | $2.33M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $4.82M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $4.21M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $4.92M 10-Q · filed 2014-10-24 |
| 2013-03-31 | $3.38M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $4.88M 10-Q · filed 2013-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |